Acyloxymethyl esters of isophosphoramide mustard as new anticancer prodrugs

Acta Poloniae Pharmaceutica - Drug Research

Volumn 70, Issue 3, 2013, Pages 481-487

  Cytarska, Joanna ^a   Misiura, Konrad ^a   Filip Psurska, Beata ^b   Wietrzyk, Joanna ^b  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Anticancer activity; Carboxyesterase; Isophosphoramide mustard; Prodrug

Indexed keywords

[BIS(2 CHLOROETHYLAMINO)PHOSPHORYLOXY]METHYL ACETATE; [BIS(2 CHLOROETHYLAMINO)PHOSPHORYLOXY]METHYL BENZOATE; [BIS(2 CHLOROETHYLAMINO)PHOSPHORYLOXY]METHYL PIVALATE; ESTER; PALIFOSFAMIDE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CYTOTOXICITY; HUMAN; LUNG CANCER; PROSTATE CANCER;

ANTINEOPLASTIC AGENTS; BIOTRANSFORMATION; CELL LINE, TUMOR; DRUG STABILITY; HUMANS; PHOSPHORAMIDE MUSTARDS; PRODRUGS;

EID: 84878044102     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Hecker S.J., Erion M.D.: J. Med. Chem. 51, 2328 (2008).
2. StaOczak A., Ferra A.: Pharmacol. Rep. 58, 599 (2006).
3. Rooseboom M., Commandeur J.N., Vermeulen N.P.E.: Pharmacol. Rev. 56, 53 (2004).
4. Satoh T., Hosokawa M.: Chem. Biol. Interact. 162, 195 (2006).
5. Satoh T., Hosokawa M.: Annu. Rev. Pharmacol. Toxicol. 38, 257 (1998).
6. Satoh T., Hosokawa M., Atsumi R., Suzuki W., Hakusui H., Nagai E.: Biol. Pharm. Bull. 17, 662 (1994).
7. Senter P.D., Marquardt H., Thomas B.A., Hammock B.D., Frank I.S., Svensson H.P.: Cancer Res. 56, 1471 (1996).
8. Denny W.A.: J. Biomed. Biotech. 1, 48, (2003).
9. Oosterhoff D., Pinedo H.M., Witlox M.A., Carette J.E., Gerritsen W.R., van Beusechem U.V.: Gene Ther. 12, 1011 (2005).
10. Ogasawara H., Nishio K., Kaznawa F., Lee Y.- S., Funayama Y., Ohira T., Kuraishi Y. et al.: Jpn. J. Cancer Res. 86, 124 (1995).
11. Sanghani S.P., Quinney S.K., Fredenburg T.B., Davis W.I., Murry D.J., Bosron W.F.: Drug Metab. Dispos. 32, 505 (2004).
12. Morton C.L., Wadkins R.M., Danks M.K., Potter P.M.: Cancer Res. 59, 1458 (1999).
13. Liederer B.M., Borchardt R.T.: J. Pharm. Sci. 95, 1177 (2006).
14. Schultz C.: Bioorg. Med. Chem. 11, 885 (2003).
15. Krise J.P., Stella V. J.: Adv. Drug Delivery Rev. 19, 287 (1996).
16. Starrett Jr. J.E., Tortolani D.R., Russel J., Hitchcock M.J., Whiterock V., Martin J.C., Mansuri M. M.: J. Med. Chem. 37, 1857 (1994).
17. Arimilli M.N., Kim C.U., Dougherty J., Mulato A., Oliyali R., Shaw J.P., Kundy K.C., Bischofberger N.: Antiviral Chem. Chemother. 8, 557 (1997).
18. Dickson Jr. J.K., Biller S.A., Magnin D.R., Petrillo Jr. E. ., Hillyer J. ., Hsieh D.C., Lan S.J.: J. Med. Chem. 39, 661 (1996).
19. Hiyoshi H., Yanagimachi M., Ito M., Ohtsuka I., Yoshidaz I., Saeki T., Tanaka H.: J. Lipid Res. 41, 1136 (2000).
20. Misiura K., Okruszek A., Pankiewicz K., Stec W J., Czownicki Z., Utracka B.: J. Med. Chem., 26, 674 (1983).
21. Zhang J., Tian Q., Chan S.Y., Li S.C., Zhou S., Duan W., Zhu Y.Z.: Drug Metab. Rev. 37, 611 (2005).
22. Carli M., Passone E., Perilongo G., Bisogno G.: Oncology 65, 99 (2003).
23. Colvin O.M.: Curr. Pharm. Des. 5, 555 (1999).
24. Springer J.B., Colvinz M.E., Colvin O.M., Ludeman S. M.: J. Org. Chem. 63, 7218 (1998).
25. Germann N., Urien S., Rodgers A.H., Ratterree M., Struck R.F., Waud W.R., Serota D.G.: Cancer Chemother. Pharmacol. 55, 143 (2005).
26. Kerbusch T., De Kraker J., Keizer H.J., Van Putten J.W., H. Groen J., Jansen R.L., Schellens J.H., Beijnen J. H.: Clin. Pharmacokinet. 40, 41 (2001).
27. Rutschow S., Thiem J., Kranz C., Marquardt T.: Bioorg. Med. Chem. 10, 4043 (2002).
28. Farquhar D., Khan S., Srivastava D.N., Saunders P. P.: J. Med. Chem. 37, 3902 (1994).
29. Duan J.-X., Jiao H., Kaizerman J., Stanton T., Evans J.W., Lan L., Lorente G. et al.: J. Med. Chem. 51, 2412 (2008).
30. Iyer R.P., Phillips L.R., Biddle J.A., Thakker D. R., Egan W.: Tetrahedron Lett. 30, 7141 (1989).
31. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., Warren J.T. et al.: J. Natl. Cancer Inst. 82, 1107 (1990).